Correlation Between Cue Biopharma and Instil Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Instil Bio, you can compare the effects of market volatilities on Cue Biopharma and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Instil Bio.

Diversification Opportunities for Cue Biopharma and Instil Bio

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cue and Instil is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Instil Bio go up and down completely randomly.

Pair Corralation between Cue Biopharma and Instil Bio

Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Instil Bio. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.04 times less risky than Instil Bio. The stock trades about -0.13 of its potential returns per unit of risk. The Instil Bio is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  3,177  in Instil Bio on September 1, 2024 and sell it today you would lose (486.00) from holding Instil Bio or give up 15.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  Instil Bio

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Cue Biopharma and Instil Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and Instil Bio

The main advantage of trading using opposite Cue Biopharma and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.
The idea behind Cue Biopharma and Instil Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets